Pharmaceuticals and Drug Development

Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

Supernus Announces SPN-830 Apomorphine Infusion Device NDA Accepted for Review by FDA

Generic name: apomorphineTreatment for: Hypomobility in Parkinson’s Disease Supernus Announces SPN-830 Apomorphine Infusion Device NDA Accepted for Review by FDA ROCKVILLE, Md., Nov. 02, 2023 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the […]
Written by
Women May Not Recognize Non-Lump Symptoms of Breast Cancer
  1. Pharmaceuticals and Drug Development

Women May Not Recognize Non-Lump Symptoms of Breast Cancer

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 3, 2023. By Lori Solomon HealthDay Reporter FRIDAY, Nov. 3, 2023 — Fewer than half of women recognize symptoms other than a lump in the breast as a potential sign of breast cancer, according to the results of a survey commissioned by The Ohio State […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

FDA Approves Voquezna (vonoprazan) for the Treatment of Erosive GERD and Relief of Heartburn Associated with Erosive GERD in Adults

FDA Approves Voquezna (vonoprazan) for the Treatment of Erosive GERD and Relief of Heartburn Associated with Erosive GERD in Adults FLORHAM PARK, N.J., Nov. 01, 2023 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, announced today the U.S. Food and Drug […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

Day One Announces FDA Acceptance of NDA and Priority Review for Tovorafenib in Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG)

Treatment for: Low-Grade Glioma Day One Announces FDA Acceptance of NDA and Priority Review for Tovorafenib in Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG) BRISBANE, Calif., Oct. 30, 2023 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for people […]
Written by
Sociodemographic Disparities Seen in Quality of Life in Children With Hearing Loss
  1. Pharmaceuticals and Drug Development

Sociodemographic Disparities Seen in Quality of Life in Children With Hearing Loss

By Lori Solomon HealthDay Reporter TUESDAY, Oct. 31, 2023 — Race and ethnicity and neighborhood disadvantage are associated with hearing-related quality of life (QOL) in deaf or hard-of-hearing (DHH) children, according to a research letter published online Oct. 30 in JAMA Network Open. Brooke R. Warren, from the University of California in San Francisco, and […]
Written by
  1. Pharmaceuticals and Drug Development

Driving Precision Medicine Forward: Bio-It World Europe Convenes in London 29-30 November 2023

LONDON—To foster collaboration among the UK and Europe’s biopharma and technology leaders who are forging new frontiers in precision medicine, the Bio-IT World Conference & Expo Europe is coming to London 29-30 November 2023.   Held in one of the world’s leading hubs for medical innovation, this annual event will focus on the latest IT […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

FDA Approves Omvoh (mirikizumab-mrkz), a First-in-Class Treatment for Adults with Moderately to Severely Active Ulcerative Colitis

FDA Approves Omvoh (mirikizumab-mrkz), a First-in-Class Treatment for Adults with Moderately to Severely Active Ulcerative Colitis INDIANAPOLIS, Oct. 26, 2023 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Omvoh™ (mirikizumab-mrkz) infusion (300 mg/15 mL)/injection (100 mg/mL), the first and only interleukin-23p19 (IL-23p19) antagonist […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

Odronextamab BLA for Treatment of Relapsed/Refractory Follicular Lymphoma (FL) and Diffuse Large B-cell Lymphoma (DLBCL) Accepted for FDA Priority Review

Treatment for: Follicular Lymphoma, Diffuse Large B-Cell Lymphoma Odronextamab BLA for Treatment of Relapsed/Refractory Follicular Lymphoma (FL) and Diffuse Large B-cell Lymphoma (DLBCL) Accepted for FDA Priority Review TARRYTOWN, N.Y., Sept. 29, 2023 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority […]
Written by
TCT: TAVR, SAVR Comparable for Severe Aortic Stenosis, Small Aortic Annulus
  1. Pharmaceuticals and Drug Development

TCT: TAVR, SAVR Comparable for Severe Aortic Stenosis, Small Aortic Annulus

By Elana Gotkine HealthDay Reporter FRIDAY, Oct. 27, 2023 — For patients with severe aortic stenosis (AS) and small aortic annulus (SAA), valve hemodynamic results are comparable with use of transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR), according to a study published online Oct. 26 in Circulation to coincide with the […]
Written by

Good Reads

Engineering Breast Cancer Cells for Tumor Vaccines

In the rapidly evolving landscape of cancer immunotherapy, a groundbreaking study has emerged from the laboratories of Martí-Díaz et al., poised to redefine therapeutic strategies for breast cancer. Published in the prestigious journal BMC Cancer, this research delves into the sophisticated engineering of phagocytic signals on breast cancer cells ex vivo, proposing a novel whole […]
Written by
5 biotech companies making waves in Wales in 2025

5 biotech companies making waves in Wales in 2025

Newsletter Signup – Under Article / In Page “*” indicates required fields Famous for its rugged coastline and scenic mountains, Wales is also home to a thriving life science industry. Supported by science parks, med-tech companies, and universities, the country has opened up avenues for a budding biotech sector, particularly for the development of startups. […]
Written by

Worlwide

Engineering Breast Cancer Cells for Tumor Vaccines

In the rapidly evolving landscape of cancer immunotherapy, a groundbreaking study has emerged from the laboratories of Martí-Díaz et al., poised to redefine therapeutic strategies for breast cancer. Published in the prestigious journal BMC Cancer, this research delves into the sophisticated engineering of phagocytic signals on breast cancer cells ex vivo, proposing a novel whole […]
Written by
5 biotech companies making waves in Wales in 2025

5 biotech companies making waves in Wales in 2025

Newsletter Signup – Under Article / In Page “*” indicates required fields Famous for its rugged coastline and scenic mountains, Wales is also home to a thriving life science industry. Supported by science parks, med-tech companies, and universities, the country has opened up avenues for a budding biotech sector, particularly for the development of startups. […]
Written by

Highlights From MR2025 – State of the Planet

In mid-June, over 400 academics, policymakers and practitioners attended MR2025: Mobility, Adaptation, and Wellbeing in a Changing Climate, hosted by the Columbia Climate School in partnership with the Global Centre for Climate Mobility and the Tamer Institute for Social Enterprise and Climate Change. Since its inception in 2019, the conference has convened every two years […]
Written by

Trending

Login

Welcome to Life Science News!
"Explore the Latest Discoveries and Breakthroughs in Life Science with Life Science News!"
Read Smart, Save Time
Pick all the topics you are interested in to fill your homepage with stories you'll love.
Join our community
Registration is closed.